STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLGN
  4. [EFFECT] CollPlant Biotechnologies Ltd SEC Filing

[EFFECT] CollPlant Biotechnologies Ltd SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 3, 2025 4:30 P.M.
Form: F-1
CIK: 0001631487
Company Name: CollPlant Biotechnologies Ltd
File Number: 333-288109

Source: View Original Filing on SEC EDGAR

Stock CLGN logo
Collplant Biotechnologies Ltd

NASDAQ:CLGN

CLGN Rankings

#5494 Ranked by Market Cap
N/A Ranked by Dividends

CLGN Latest News

Aug 25, 2025
CollPlant to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
Aug 20, 2025
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Aug 5, 2025
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS
Jul 14, 2025
CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations
Jun 9, 2025
COLLPLANT BROADENS ITS COLLABORATION WITH STEMCELL TECHNOLOGIES

CLGN Latest SEC Filings

Aug 20, 2025
[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer)
Jul 14, 2025
[6-K] CollPlant Biotechnologies Ltd Current Report (Foreign Issuer)
Jul 3, 2025
[424B3] CollPlant Biotechnologies Ltd Prospectus Filed Pursuant to Rule 424(b)(3)

CLGN Stock Data

33.44M
8.91M
10.16%
12.23%
0.85%
Biotechnology
Healthcare
Link
Israel
Rehovot